Stoke Therapeutic reports encouraging results for epilepsy drug
The gene-based drug reduced the frequency of seizures by 43 percent to 85 percent in 34 patients who participated in four early-stage studies.
Source: bostonglobe.com
Stay updated with breaking news from Most Dravet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The gene-based drug reduced the frequency of seizures by 43 percent to 85 percent in 34 patients who participated in four early-stage studies.